Jeroen van Kampen

Jeroen van Kampen is a Researcher in the Department of Virology at Erasmus MC, part of Erasmus University Rotterdam. His work focuses on viral infectious diseases, particularly HIV and emerging viruses like SARS-CoV-2. He investigates drug resistance mechanisms, viral evolution, and the clinical impact of antiretroviral therapies. His research spans molecular epidemiology, host-pathogen interactions, and public health outcomes in immunocompromised populations.

Key research interests include HIV drug resistance interpretation, HLA-mediated viral suppression, and norovirus dynamics in vulnerable patients. He collaborates internationally on multicohort studies to analyze long-term trends in HIV-related mortality and evaluate novel treatment regimens like doravirine-based therapies.

Recent work highlights the evolution of HIV-2 resistance patterns and the genetic factors influencing viral persistence. His studies often integrate computational methods with clinical data to address translational challenges in virology and infectious disease management.

Van Kampen’s publications reflect a commitment to improving treatment guidelines and understanding viral adaptation. He contributes to standardized interpretations of drug resistance mutations and evaluates real-world therapy effectiveness through prospective cohort analyses.